A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This trial is a registered phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in patients with unresectable locally advanced, recurrent, or metastatic HR+HER2- breast cancer after failure of at least one prior line of chemotherapy.
Epistemonikos ID: a39bee9af4723dbbb77945821e512ebbbcd9c4f5
First added on: May 15, 2024